Martel Jean-Claude, Leduc Nathalie, Ormière Anne-Marie, Faucillon Valérie, Danty Nathalie, Culie Charlène, Cussac Didier, Newman-Tancredi Adrian
Division of Neurobiology 2 Centre de recherche Pierre Fabre, 17 avenue Jean Moulin, 81106 Castres cedex, France.
Eur J Pharmacol. 2007 Nov 21;574(1):15-9. doi: 10.1016/j.ejphar.2007.07.015. Epub 2007 Jul 13.
The serotonin 5-HT(1A) receptor antagonist WAY-100635 was recently reported to have potent agonist properties at dopamine D(4) receptors (Chemel et al., 2006, Psychopharmacology 188, 244-251.). Herein WAY-100635 (pK(i) at human (h) serotonin 5-HT(1A) receptors=9.51; pK(i) at dopamine hD(4.4) receptors=7.42) stimulated [(35)S]GTPgammaS incorporation in membranes of Chinese Hamster Ovary cells expressing dopamine hD(4.4) receptors with only moderate potency and modest efficacy (pEC(50)=6.63; E(max)=19% of dopamine). Moreover, in antagonism experiments, WAY-100635 had a much lower potency at dopamine hD(4.4) receptors (pK(B)=7.09), than at serotonin h5-HT(1A) receptors (pK(B)=9.47). These data demonstrate that WAY-100635 has high selectivity for serotonin h5-HT(1A)versus dopamine hD(4.4) receptors.
血清素5-HT(1A)受体拮抗剂WAY-100635最近被报道在多巴胺D(4)受体上具有强效激动剂特性(Chemel等人,2006年,《精神药理学》188卷,244 - 251页)。在此,WAY-100635(对人(h)血清素5-HT(1A)受体的pK(i)=9.51;对多巴胺hD(4.4)受体的pK(i)=7.42)刺激表达多巴胺hD(4.4)受体的中国仓鼠卵巢细胞的膜中[(35)S]GTPγS的掺入,其效力中等且效能适度(pEC(50)=6.63;E(max)=多巴胺的19%)。此外,在拮抗实验中,WAY-100635在多巴胺hD(4.4)受体上的效力(pK(B)=7.09)远低于在血清素h5-HT(1A)受体上的效力(pK(B)=9.47)。这些数据表明WAY-100635对血清素h5-HT(1A)受体相对于多巴胺hD(4.4)受体具有高选择性。